Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.9% normal saline (control)----[1] 299
2Active Control----[1] 13
3Amitriptyline, fluoxetine and tramadol alone (control group)[3] Amitriptyline,
Fluoxetine,
Tramadol		[3] D00326 ,
D07448 ,
D08623 		[3] OPRM1,
SLC6A2,
SLC6A4 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 78
4Boots High Strength Garlic Odour Controlled[1] Garlic[1] D12020 --[1] 299
5BPR277 ointment (controlled application)----[1] 160
6Carbidopa and Levodopa Controlled Release Tablets[2] Carbidopa,
Levodopa		[2] D00059 ,
D00558 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
7Coenzyme Q-10 in Normal Control subjects[1] Ubidecarenone[1] D01065 --[1] 86
8Control----[4] 6, 46, 168, 299
9Control gel----[1] 36
10Control group----[4] 2, 13, 46, 70
11Control Group 0.9% Isotonic Saline----[1] 299
12Control intervention (no dexamethasone)[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
13Control multivitamin----[1] 299
14Controlled-release levodopa / carbidopa[2] Carbidopa,
Levodopa		[2] D00059 ,
D00558 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
15Cornstarch control[1] Starch, corn (Synonym: Lotrimin Daily Sweat and Odor Control)[1] D05297 --[1] 90
16Diazoxide choline controlled-release tablet[2] Choline,
Diazoxide		[2] D00294 ,
D07690 		[2] ABCC8,
KCNJ11 💬		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 193
17Epilim Chrono 200 Controlled Released tablets----[1] 256
18Epilim Chrono 300 Controlled Released tablets----[1] 256
19Epilim Chrono 500 Controlled Released tablets----[1] 256
20Group 1- Control Diet----[1] 97
21High dose vehicle control----[1] 46
22Infliximab Control[1] Infliximab[1] D02598 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
23Levodopa CR (controlled release)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
24Low dose vehicle control----[1] 46
25Ropinirole controlled-release (REQUIP CR) for RLS[1] Ropinirole[1] D08489 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
26Sinemet® controlled release (Carbidopa/levodopa)[2] Carbidopa,
Levodopa		[2] D00059 ,
D00558 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
27Treatment vs control bread----[1] 97
28Vehice Control----[1] 96
29Vehicle Control----[1] 53